Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Issues on antiretroviral post exposure combination prophylaxis

V Puro1, G Ippolito

  • 1Centro di Riferimento AIDS, IRCCS-Ospedale Lazzaro Spallanzani, Roma, Italy.

Journal of Biological Regulators and Homeostatic Agents
|January 1, 1997
PubMed
Summary

Early antiretroviral chemoprophylaxis, known as post-exposure prophylaxis (PEP), significantly reduces HIV transmission risk. Combination therapy is recommended, initiated within 4 hours for optimal effectiveness.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Changes in body composition in early breast cancer patients treated with aromatase inhibitors.

Journal of endocrinological investigation·2024
Same author

Vaccination for monkeypox prevention in persons with high-risk sexual behaviours to control on-going outbreak of monkeypox virus clade 3.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2022
Same author

Deep learning-based single image super-resolution for low-field MR brain images.

Scientific reports·2022
Same author

Thyroid dysfunction in COVID-19 patients.

Journal of endocrinological investigation·2021
Same author

COVID-19 and tuberculosis-threats and opportunities.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2020
Same author

COVID-19 and renin-angiotensin system inhibition: role of angiotensin converting enzyme 2 (ACE2) - Is there any scientific evidence for controversy?

Journal of internal medicine·2020

Area of Science:

  • Infectious Diseases
  • Virology
  • Public Health

Background:

  • Early antiretroviral chemoprophylaxis demonstrates efficacy in reducing HIV transmission.
  • Evidence from in vitro studies, animal models, and healthcare worker exposures supports its use.
  • Treatment of acute infection and prevention of vertical transmission further corroborate efficacy.

Purpose of the Study:

  • To review the evidence supporting early antiretroviral chemoprophylaxis (PEP) after HIV exposure.
  • To outline current recommendations for combination post-exposure prophylaxis (PEP) regimens.
  • To discuss contraindications, specific exposure scenarios, and future research needs.

Main Methods:

  • Review of existing in vitro studies, animal experiments, and case-control studies.

Related Experiment Videos

  • Analysis of clinical trial data on acute HIV infection and vertical transmission prevention.
  • Synthesis of recommendations for combination antiretroviral therapy.

    • Main Results:

    • Combination PEP is recommended for enhanced antiretroviral activity and to combat resistance.
    • Regimens may include a second reverse transcriptase inhibitor and a protease inhibitor for high-risk exposures.
    • Initiation within 1-4 hours and a four-week duration are advised.

    Conclusions:

    • PEP is a critical intervention for preventing HIV transmission across various exposure types.
    • Management requires specialized expertise and organized services.
    • Ongoing data collection through registries is essential for refining PEP protocols and ensuring best practices.